Yan-Ming Huang Selected Research

Yan-Ming Huang Research Topics

3	Glioma (Gliomas) 01/2016 - 10/2014
2	Glioblastoma (Glioblastoma Multiforme) 07/2015 - 10/2014
1	Bilateral Choroidal Osteoma 01/2020
1	Polypoidal Choroidal Vasculopathy 01/2020
1	Uterine Rupture 10/2019
1	Oligohydramnios 10/2019
1	Lacerations 10/2019
1	Rupture 10/2019
1	Lung Injury 02/2017
1	Fibrosis (Cirrhosis) 02/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2017
1	Foreign Bodies (Foreign Body) 01/2017
1	Bone Resorption 02/2015
1	Neoplasms (Cancer) 01/2015
1	Osteoporosis 01/2015

2	Diphosphonates (Bisphosphonates)IBA 02/2015 - 01/2015
2	NitrogenIBA 02/2015 - 01/2015
1	KH902 fusion proteinIBA 01/2020
1	Mifepristone (RU 486)FDA Link 10/2019
1	Misoprostol (Cytotec)FDA LinkGeneric 10/2019
1	Ethacridine (Ethacridine Lactate)IBA 10/2019
1	Matrix Metalloproteinases (MMPs)IBA 02/2017
1	Metalloproteases (Metalloproteinases)IBA 02/2017
1	indium-bleomycinIBA 02/2017
1	Bosentan (Tracleer)FDA Link 02/2017
1	Bleomycin (Blenoxane)FDA LinkGeneric 02/2017
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Alkylating AgentsIBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Temozolomide (Temodar)FDA LinkGeneric 01/2016
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2016
1	Arecoline (Arecolin)IBA 07/2015
1	Intermediate-Conductance Calcium-Activated Potassium ChannelsIBA 07/2015
1	SodiumIBA 02/2015
1	PlatinumIBA 01/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2015
1	Ion Channels (Ion Channel)IBA 01/2015
1	IonomycinIBA 01/2015
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2014
1	Antineoplastic Agents (Antineoplastics)IBA 10/2014
1	AminesIBA 10/2014
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 10/2014
1	6- chloro- 9- (4- methoxy- 3,5- dimethylpyridin- 2- ylmethyl)- 9H- purin- 2- ylamineIBA 10/2014
1	tanespimycin (17AAG)IBA 10/2014